Pasithea Share Price

Pasithea Share Price

NASDAQ: KTTA | Micro Cap | Healthcare
$0.47
-$0.01 (-1.71%) Last updated on 21 Nov, 2026 | 01:48 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Pasithea Stock Performance

Open
$0.47
Prev. Close
$0.48
Circuit Range
N/A
Day Range
$0.47 - $0.48
Year Range
$0.29 - $2.06
Volume
7,460
Average Traded
$0.47

Pasithea Share Price Today

As of 22 November 2026, Pasithea Therapeutics Corp.'s share price is $0.47. The stock opened at $0.47, compared to its previous close of $0.48. During today's trading session, Pasithea Therapeutics Corp.'s share price traded between $0.47 and $0.48, with an average price of $0.47. Over the past 52 weeks, the stock has recorded a high of $2.06 and a low of $0.29. In terms of performance, Pasithea Therapeutics Corp.'s share price has declined by 33.56% over the last six months and is down 67.64% on a year-on-year basis.

Pasithea Share Price Chart

Line chart of the Pasithea price trend over the selected period. The price fell overall, ranging from 0.47 to 0.47, ending at 0.47.
$0.47$0.48
L
Show Current Price
H

Pasithea Stock Fundamentals & Key Indicators

Market Cap
$3.32M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.68
Revenue (TTM)
$0.00
Return On Equity (TTM)
-56.78%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
34.92%

Pasithea Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$10.11-$2.87-$5.27-$6.58
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A71.61%-83.62%-24.86%

Pasithea Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$13.94-$15.96-$13.90-$20.43
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-14.49%12.91%-46.98%

Pasithea Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets3.788.79.4211.1
Current Assets56.467.3716.6934.08
Total Assets60.2416.0626.1245.18
Non Current Liabilities0.050.160.080.58
Current Liabilities4.971.122.631.96
Total Liabilities5.021.282.722.54
Shareholders' Equity55.2214.7823.442.64

Pasithea Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-15.21-13.92-13.43-13.69
Investing0.010.00.4-2.93
Financing63.524.52-3.73-3.21

Corporate Actions

Split
Ex-date: 02 Jan 2024

About Pasithea

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. The disorders covered includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module). The Company has reportable segment, which is the business of research and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers.

Pasithea Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$0.40
$0.47
+24.21%
Oct 2026
$0.46
$0.38
-23.08%
Sep 2026
$0.55
$0.49
-10.99%
Aug 2026
$0.45
$0.56
+19.35%
Jul 2026
$0.59
$0.47
-9.36%
Jun 2026
$0.71
$0.51
-27.85%
May 2026
$0.72
$0.71
+0.71%
Apr 2026
$0.65
$0.71
-5.87%
Mar 2026
$0.83
$0.75
-8.42%
Feb 2026
$0.85
$0.82
-4.99%
Jan 2026
$1.23
$0.86
-33.69%
Dec 2025
$1.25
$1.30
-10.96%

Pasithea Share Price FAQs